Compare MasTec Inc (MTZ) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs ResMed Inc. — how do they compare? MasTec Inc trades at $348.86 (market cap $26.60B), while ResMed Inc. trades at $197.45 (market cap $28.81B). The key difference: MasTec Inc and ResMed Inc. are close in size by market cap, and ResMed Inc. pays a 1.21% dividend while MasTec Inc pays none. Which is the better fit depends on your goals.
| MTZ | RMD | |
|---|---|---|
Market Cap | $26.60B | $28.81B |
Sector | Technology | Health |
52-Week High | $437.51 | $293.73 |
52-Week Low | $172.51 | $182.82 |
Enterprise Value | $29.34B | $27.99B |
Dividend Yield | — | 1.21% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
